LifeStance Health Group, Inc. (LFST)
NASDAQ · Healthcare
LifeStance Health Group, Inc. EBITDA 2019–2025
LifeStance Health Group, Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- LifeStance Health Group, Inc. ebitda for the quarter ending March 31, 2026 was 32.6 M, a 174.51% increase year-over-year.
- LifeStance Health Group, Inc. ebitda for the twelve months ending March 31, 2026 was 70.0 M, a 204.42% decrease year-over-year.
- LifeStance Health Group, Inc. annual ebitda for 2025 was 65.8 M, a 625.58% increase from 2024.
- LifeStance Health Group, Inc. annual ebitda for 2024 was 9.1 M, a 105.97% decrease from 2023.
- LifeStance Health Group, Inc. annual ebitda for 2023 was -151.8 M, a 16.27% decrease from 2022.
- LifeStance Health Group, Inc. annual ebitda for 2022 was -181.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
LifeStance Health Group, Inc. EBITDA — FAQ
LifeStance Health Group, Inc. (LFST) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LFST's ebitda history?
The chart and table above show LifeStance Health Group, Inc.'s ebitda by year and by quarter, including the growth rate.